JOHN HOPE FRANKLIN CENTER

JOHN HOPE FRANKLIN CENTER logo
🇺🇸United States
Ownership
Private
Established
1838-01-01
Employees
5K
Market Cap
-
Website
http://www.duke.edu

Comparing Paroxetine and Duloxetine on Cardiovascular Measures

Phase 2
Completed
Conditions
First Posted Date
2005-08-29
Last Posted Date
2014-07-21
Lead Sponsor
Duke University
Target Recruit Count
40
Registration Number
NCT00136383
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-08-25
Last Posted Date
2014-09-16
Lead Sponsor
Duke University
Target Recruit Count
33
Registration Number
NCT00134680
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

🇺🇸

Siteman Cancer Center, Washington University, St. Louis, Missouri, United States

🇺🇸

Lombardi Cancer Institute, Georgetown University Medical Center, Washington, District of Columbia, United States

and more 1 locations

A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel

First Posted Date
2005-08-19
Last Posted Date
2016-07-25
Lead Sponsor
Duke University
Target Recruit Count
94
Registration Number
NCT00131963
Locations
🇺🇸

Duke Cancer Institute, Durham, North Carolina, United States

Comparison of Two Programs to Improve Blood Pressure Treatment Adherence

First Posted Date
2005-07-22
Last Posted Date
2014-09-08
Lead Sponsor
Duke University
Target Recruit Count
777
Registration Number
NCT00123058
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Investigational Study of Psychological Intervention in Recipients of Lung Transplant (INSPIRE)

First Posted Date
2005-06-06
Last Posted Date
2014-07-14
Lead Sponsor
Duke University
Target Recruit Count
389
Registration Number
NCT00113139

Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2004-08-31
Last Posted Date
2015-02-25
Lead Sponsor
Duke University
Target Recruit Count
150
Registration Number
NCT00090610
Locations
🇺🇸

Franklin Square Hospital Center/MedStar Health-Section of Hematology/Oncology, Baltimore, Maryland, United States

🇺🇸

Hope: A Woman's Cancer Center, Asheville, North Carolina, United States

🇺🇸

Columbia University College of Physicians and Surg, New York, New York, United States

and more 16 locations

Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal

Phase 1
Completed
Conditions
First Posted Date
2004-08-25
Last Posted Date
2013-03-25
Lead Sponsor
Duke University
Registration Number
NCT00003229
Locations
🇺🇸

Duke Comprehensive Cancer Center, Durham, North Carolina, United States

🇺🇸

Cancer Center, University of Virginia HSC, Charlottesville, Virginia, United States

Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain

Phase 1
Completed
Conditions
First Posted Date
2004-08-16
Last Posted Date
2013-02-20
Lead Sponsor
Duke University
Target Recruit Count
56
Registration Number
NCT00003348
Locations
🇺🇸

Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Carboplatin in Patients With Progressive Gliomas

Phase 2
Completed
Conditions
First Posted Date
2004-08-11
Last Posted Date
2009-10-14
Lead Sponsor
Duke University
Target Recruit Count
25
Registration Number
NCT00002749
Locations
🇺🇸

Duke Comprehensive Cancer Center, Durham, North Carolina, United States

🇨🇦

Hopital Sainte Justine, Montreal, Quebec, Canada

Flt3L in Treating Patients With Metastatic Colorectal Cancer

Phase 1
Completed
Conditions
First Posted Date
2004-08-04
Last Posted Date
2013-03-05
Lead Sponsor
Duke University
Registration Number
NCT00003431
Locations
🇺🇸

Duke Comprehensive Cancer Center, Durham, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath